BioPharmX secures IRB approval to start Phase ll trial of BPX-04
BioPharmX has received approval from the Institutional Review Board (IRB) to begin a PRISM Phase ll trial to examine the…
rosacea BioPharmX
BioPharmX has received approval from the Institutional Review Board (IRB) to begin a PRISM Phase ll trial to examine the…